292 related articles for article (PubMed ID: 31704507)
21. The multifaceted photocytotoxic profile of hypericin.
Theodossiou TA; Hothersall JS; De Witte PA; Pantos A; Agostinis P
Mol Pharm; 2009; 6(6):1775-89. PubMed ID: 19739671
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic mechanisms induced by a combination of hypericin and a chlorin based-photosensitizer in head and neck squamous cell carcinoma cells.
Gyenge EB; Lüscher D; Forny P; Antoniol M; Geisberger G; Walt H; Patzke G; Maake C
Photochem Photobiol; 2013; 89(1):150-62. PubMed ID: 22882495
[TBL] [Abstract][Full Text] [Related]
23. Response surface method optimization of a novel Hypericin formulation in P123 micelles for colorectal cancer and antimicrobial photodynamic therapy.
Montanha MC; Silva LL; Pangoni FBB; Cesar GB; Gonçalves RS; Caetano W; Hioka N; Tominaga TT; Consolaro MEL; Diniz A; Kimura E
J Photochem Photobiol B; 2017 May; 170():247-255. PubMed ID: 28454049
[TBL] [Abstract][Full Text] [Related]
24. Importance of Hypericin-Bcl2 interactions for biological effects at subcellular levels.
Stroffekova K; Tomkova S; Huntosova V; Kozar T
Photodiagnosis Photodyn Ther; 2019 Dec; 28():38-52. PubMed ID: 31430575
[TBL] [Abstract][Full Text] [Related]
25. Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin.
Kleban J; Szilárdiová B; Mikes J; Horváth V; Sacková V; Brezáni P; Hofmanová J; Kozubík A; Fedorocko P
J Photochem Photobiol B; 2006 Aug; 84(2):79-88. PubMed ID: 16545574
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin.
Kleban J; Mikes J; Horváth V; Sacková V; Hofmanová J; Kozubík A; Fedorocko P
J Photochem Photobiol B; 2008 Nov; 93(2):108-18. PubMed ID: 18771933
[TBL] [Abstract][Full Text] [Related]
27. Increasing the efficiency of hyperthermic intraperitoneal chemotherapy (HIPEC) by combination with a photosensitive drug in pediatric rhabdomyosarcoma in an animal model.
Wagner BR; Adamus AL; Hempfling L; Vahdad R; Haap-Hoff A; Heinrich B; Vázquez O; Jank P; Denkert C; Seitz G
Pediatr Blood Cancer; 2022 Nov; 69(11):e29864. PubMed ID: 35731577
[TBL] [Abstract][Full Text] [Related]
28. Hypericin in phototherapy.
Koren H; Schenk GM; Jindra RH; Alth G; Ebermann R; Kubin A; Koderhold G; Kreitner M
J Photochem Photobiol B; 1996 Nov; 36(2):113-9. PubMed ID: 9002247
[TBL] [Abstract][Full Text] [Related]
29. Hypericin-PDT-induced rapid necrotic death in human squamous cell carcinoma cultures after multiple treatment.
Sharma KV; Davids LM
Cell Biol Int; 2012; 36(12):1261-6. PubMed ID: 23005701
[TBL] [Abstract][Full Text] [Related]
30. Hypericin photodynamic activity in DPPC liposome. PART I: biomimetism of loading, location, interactions and thermodynamic properties.
de Morais FAP; Gonçalves RS; Vilsinski BH; de Oliveira ÉL; Rocha NL; Hioka N; Caetano W
J Photochem Photobiol B; 2019 Jan; 190():118-127. PubMed ID: 30513414
[TBL] [Abstract][Full Text] [Related]
31. Conjunction of glutathione level, NAD(P)H/FAD redox status and hypericin content as a potential factor affecting colon cancer cell resistance to photodynamic therapy with hypericin.
Mikešová L; Mikeš J; Kovaľ J; Gyurászová K; Culka L; Vargová J; Valeková B; Fedoročko P
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):470-83. PubMed ID: 24284100
[TBL] [Abstract][Full Text] [Related]
32. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
Du HY; Bay BH; Olivo M
Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
[TBL] [Abstract][Full Text] [Related]
33. Hypericin-P123-photodynamic therapy in an ex vivo model as an alternative treatment approach for onychomycosis caused by Fusarium spp.
Conrado PCV; Sakita KM; Arita GS; Gonçalves RS; Cesar GB; Caetano W; Hioka N; Voidaleski MF; Vicente VA; Svidzinski TIE; Bonfim-Mendonça PS; Kioshima ES
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102414. PubMed ID: 34186264
[TBL] [Abstract][Full Text] [Related]
34. Hypericin in photobiological assays: An overview.
de Andrade GP; de Souza TFM; Cerchiaro G; Pinhal MADS; Ribeiro AO; Girão MJBC
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102343. PubMed ID: 34038765
[TBL] [Abstract][Full Text] [Related]
35. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells.
Wang X; Guo Y; Yang S; Wang C; Fu X; Wang J; Mao Y; Zhang J; Li Y
J Pharmacol Exp Ther; 2010 Sep; 334(3):847-53. PubMed ID: 20551295
[TBL] [Abstract][Full Text] [Related]
36. Hypericin in cancer treatment: more light on the way.
Agostinis P; Vantieghem A; Merlevede W; de Witte PA
Int J Biochem Cell Biol; 2002 Mar; 34(3):221-41. PubMed ID: 11849990
[TBL] [Abstract][Full Text] [Related]
37. Hypericin-Apomyoglobin: An Enhanced Photosensitizer Complex for the Treatment of Tumor Cells.
Bianchini P; Cozzolino M; Oneto M; Pesce L; Pennacchietti F; Tognolini M; Giorgio C; Nonell S; Cavanna L; Delcanale P; Abbruzzetti S; Diaspro A; Viappiani C
Biomacromolecules; 2019 May; 20(5):2024-2033. PubMed ID: 30995399
[TBL] [Abstract][Full Text] [Related]
38. Photodynamic effect of hypericin on the microorganisms and primary human fibroblasts.
Kashef N; Borghei YS; Djavid GE
Photodiagnosis Photodyn Ther; 2013 May; 10(2):150-5. PubMed ID: 23769281
[TBL] [Abstract][Full Text] [Related]
39. An Electron paramagnetic resonance (EPR) spin labeling study in HT-29 Colon adenocarcinoma cells after Hypericin-mediated photodynamic therapy.
Yonar D; Kılıç Süloğlu A; Selmanoğlu G; Sünnetçioğlu MM
BMC Mol Cell Biol; 2019 Jun; 20(1):16. PubMed ID: 31221093
[TBL] [Abstract][Full Text] [Related]
40. Successful in vivo tumor visualization using fluorescence laparoscopy in a mouse model of disseminated alveolar rhabdomyosarcoma.
Urla C; Armeanu-Ebinger S; Fuchs J; Seitz G
Surg Endosc; 2015 May; 29(5):1105-14. PubMed ID: 25149634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
